Navigation Links
EnrichMap Announces New Program To Reduce Medical Patient Noncompliance And Offers Healthcare Organizations A Limited Trial Test Opportunity
Date:10/8/2008

Medical patient noncompliance is a major healthcare issue. The Emap typology provides a new patient assessment program to determine the compliance personality of individuals and then targeted guidance for how to best communicate healthcare information to each of the six compliance Profiles

(PRWEB) October 8, 2008 -- www.enrichmap.com [EnrichMap __title__ Click this link.] announces new program to reduce medical www.enrichmap.com [patient noncompliance __title__ Click this link.]and offers healthcare organizations a limited trial test opportunity.

EnrichMap has developed a new methodology to identify the www.enrichmap.com [medical compliance personality] of individual patients and then employ a more targeted, personalized approach to increasing compliance. EnrichMap is seeking organizations in the healthcare industry to conduct demonstration tests of the Emap Profile to predict and manage patient compliance. The trial programs are available for a limited time at no cost to the clients.

The Emap research indicates that each person has a core compliance personality which shapes their attitudes and behavior in adhering to healthcare regimens. The Emap Profile identifies six Compliance Personality Groups, each of which can now be addressed with a targeted approach to healthcare communications and treatment styles that help to enlist the patient to be more responsive and participatory in their own healthcare program.

Clinical trial researchers can use Emap to determine the likelihood of a subject completing a trial and following a defined protocol. Healthcare providers and insurance companies can suggest protocols, communications and treatment styles that better match the nature of the patient, to increase the likelihood of achieving desired outcomes and reduce costs.

Dr. Allan Showalter and several colleagues, after studying noncompliance for many years in their own
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...FAYETTE, Ind. - A new generation of ultrasmall tra...ny structures called semiconducting nanowires are ...hers at IBM, Purdue University and the University ...have learned how to create nanowires with layers o...the atomic level, which is a critical requirement ...
(Date:11/25/2009)... Ambassador to Speak at Economic Club ...da (Vocus) November 25, 2009 -- Ambassador to Spea... Appia, French Ambassador for International Invest... Agency ,To view a biography of David Appia go to ...Appia is available to meet with press to discuss r...
(Date:11/25/2009)... , BEIJING, Nov. 25 /PRNewswire-Asia/ -- Si... provider of vaccines, announced today that it exe...Sinovac (Dalian) Vaccine,Technology Co., Ltd. (Sin...ce,and commercialize human-use vaccines. Sinovac w...eloping and commercializing world-class vaccines; ...
(Date:11/24/2009)...se is available in German . , Whether it,s ...RFID tags (Radio Frequency Identification) are inc...ey make it possible to label objects or goods and ...e appropriate scanner can read and process the dat...xed to goods under production conditions of up to ...
Breaking Biology Technology:Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3French Ambassador for International Investment to Visit Toronto December 11 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Intelligence inside metal components 2
...ration today announced that The Michael J. Fox Fou...lestones to support the Company,s collaboration wi...ecent discovery of a new target for the treatment ...brain responsible for Parkinson,s disease, Omeros ...ment of any movement disorder, including Parkinson...
...UCKLAND, New Zealand, Jan. 6 MicroDose Technologi...at they have entered into a collaboration to inves...e(TM) technology with MicroDose,s next generation ...rms of the agreement, MicroDose will fund the deve...er platform and incorporating Nexus6,s Smartinhale...
...o Corporation,(Nasdaq: VOLC ), a leader in the d...r the diagnosis and treatment of coronary and peri...participating in the 27th Annual J.P.,Morgan Healt...he presentation by Scott Huennekens, president and... Pacific Standard Time (11:30 a.m., Eastern,Standa...
Other Biology Technology:Omeros Awarded Grant from The Michael J. Fox Foundation to Evaluate Novel Parkinson's Disease Target 2Omeros Awarded Grant from The Michael J. Fox Foundation to Evaluate Novel Parkinson's Disease Target 3MicroDose and Nexus6 Announce Collaboration to Evaluate Application of Remote Patient Compliance Monitoring Technology with MicroDose's Electronic Dry Powder Inhaler 2MicroDose and Nexus6 Announce Collaboration to Evaluate Application of Remote Patient Compliance Monitoring Technology with MicroDose's Electronic Dry Powder Inhaler 3Volcano Corporation Presentation at J.P. Morgan Conference to be Webcast 2
(Date:11/25/2009)...firefighters, police officers and ambulance worker...ade Center complex. They battled to save people fr...ors, tackled fires and evacuated as many people as...d 17,000 people. And making their jobs even harder...d workers and their relatives jammed mobile networ...
(Date:11/25/2009)...n you eat may be just as vital to your health as w...te for Biological Studies. Their experiments in mi...ousands of genes in the liverthe body,s metabolic ...nd not by the body,s circadian clock as convention... the activity of a large number of genes completel...
(Date:11/24/2009)...weakened and flabby arteries from collapsing have ... stents are no longer needed -- once the arteries ...sly, doctors had no choice but to leave them in pl...sity,s Department of Biomedical Engineering has de...arries drugs where they,re needed, then dissolves....
Breaking Biology News(10 mins):Magic box for mission impossible 2Magic box for mission impossible 3Feeding the clock 2Feeding the clock 3A coating for life 2Repligen Elects Glenn L Cooper M D to the Board of Directors 13677 1Repligen Elects Glenn L Cooper M D to the Board of Directors 13677 2Repligen Elects Glenn L Cooper M D to the Board of Directors 13677 3Delcath Systems Inc Announces Patient Recruitment Exceeds 90 25 55233 1Delcath Systems Inc Announces Patient Recruitment Exceeds 90 25 55233 2Delcath Systems Inc Announces Patient Recruitment Exceeds 90 25 55233 3MarketsandMarkets 3A Top Ten Medical Device Technologies Market Worth 24454 3 Billion by 2014 55230 1MarketsandMarkets 3A Top Ten Medical Device Technologies Market Worth 24454 3 Billion by 2014 55230 2MarketsandMarkets 3A Top Ten Medical Device Technologies Market Worth 24454 3 Billion by 2014 55230 3
... evolution and creationism are often shaped by wha...s, according to a University of Minnesota study pu...nal of the American Institute of Biological Scienc...rofessors in the College of Biological Sciences, s... classes at the University of Minnesota to learn h...
... the venomous murder of the mighty Thor, the serpe...e of mischief and misery. , The worldwide promin...erscores our deep connection to the serpentbut why... The surprising answer, University of California, ...ests, lies in the singular impact of snakes on pri...
...ral disease blighting many of the world,s tropical...gypti , 40% of the world,s population is believed ...evious exposure to other strains of the fever does...ions are significantly worse, and can result in fa...ioning vaccine forced Scott O,Neill and Elizabeth ...
Other Biology News:U of Minnesota study finds high school teachers influence student views of evolution & creationism 2Mosquito parasite may help fight dengue fever 2
...OSPEC 6300 (YELLOW), 1 EA. Ultrospec 6300 pro UV... requirements of the Pharmacopoeia in terms of ins...th the benefits of being able to be used for rapid... excellent scanning capability., *Press to read hi...
Human CCL21 / 6Ckine, Unconjugated, Fc Chimera from R&D Systems
EZ-96 DNA Methylation-Gold Kit from Zymo Research
Kinase Chemiluminescent Assay Kit from Upstate
Biology Products: